Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR01347
|
|||||
Drug Name |
Raloxifene
|
|||||
Synonyms |
Raloxifene (extended-release, CDT)
|
|||||
Drug Type |
Small molecular drug
|
|||||
Indication | Osteoporosis [ICD11:FB83.1] | Approved | [1] | |||
Structure |
|
![]() |
||||
3D MOL | 2D MOL | |||||
Formula |
C28H27NO4S
|
|||||
Canonical SMILES |
C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O
|
|||||
InChI |
InChI=1S/C28H27NO4S/c30-21-8-4-20(5-9-21)28-26(24-13-10-22(31)18-25(24)34-28)27(32)19-6-11-23(12-7-19)33-17-16-29-14-2-1-3-15-29/h4-13,18,30-31H,1-3,14-17H2
|
|||||
InChIKey |
GZUITABIAKMVPG-UHFFFAOYSA-N
|
|||||
CAS Number |
CAS 84449-90-1
|
|||||
Pharmaceutical Properties | Molecular Weight | 473.6 | Topological Polar Surface Area | 98.2 | ||
Heavy Atom Count | 34 | Rotatable Bond Count | 7 | |||
Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 6 | |||
XLogP |
6.1
|
|||||
PubChem CID | ||||||
PubChem SID |
9437
,831017
,5392969
,7890214
,7980482
,8153100
,11111733
,11111734
,11364773
,11367335
,11369897
,11372937
,11375497
,11378062
,11466890
,11468010
,11486560
,14834427
,24277274
,26705265
,29224106
,46506514
,46519463
,47213213
,47365304
,47662399
,47810849
,47810850
,48035235
,48185088
,48259344
,48416509
,49698670
,50065297
,50105675
,50139488
,50898374
,53788657
,56310724
,56312953
,56313701
,56352882
,56427219
,57322575
,90341181
,91148450
,92308782
,93165668
,93166953
,96025151
|
|||||
ChEBI ID |
CHEBI:8772
|
|||||
TTD Drug ID | ||||||
DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
References | ||||||
1 | Raloxifene was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
2 | Influence of hepatic and intestinal efflux transporters and their genetic variants on the pharmacokinetics and pharmacodynamics of raloxifene in osteoporosis treatment. Transl Res. 2012 Oct;160(4):298-308. |
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.